Heckel, Franziska http://orcid.org/0000-0002-7564-1932
Turaj, Anna H.
Fisher, Hayden
Chan, H. T. Claude
Marshall, Michael J. E. http://orcid.org/0000-0001-5410-0582
Dadas, Osman
Penfold, Christine A.
Inzhelevskaya, Tatyana
Mockridge, C. Ian
Alvarado, Diego
Tews, Ivo
Keler, Tibor
Beers, Stephen A. http://orcid.org/0000-0002-3765-3342
Cragg, Mark S. http://orcid.org/0000-0003-2077-089X
Lim, Sean H. http://orcid.org/0000-0002-2768-4858
Funding for this research was provided by:
Cancer Research UK (A27452)
RCUK | Medical Research Council
Celldex Therapeutics
Cancer Research UK Advanced Clinician Scientist Fellowship grant reference: A27179
Article History
Received: 7 October 2021
Accepted: 17 February 2022
First Online: 14 March 2022
Competing interests
: S.H.L. is a co-inventor on a patent application filed (JDM84560P.GBA), receives research funding from and has acted as a consultant to Celldex Therapeutics. F.H. receives research funding from Celldex Therapeutics. M.S.C. is also a co-inventor on patent application filed (JDM84560P.GBA). D.A. and T.K. are employees and shareholders of Celldex Therapeutics. The remaining authors declare no competing interests.